ReviewDiscover oncology2026

mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.

Mahsa Hosseini Kakroudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.